Biotech

All Articles

James Wilson leaving Penn to introduce 2 brand new biotechs

.After much more than 30 years, gene treatment pioneer James Wilson M.D., Ph.D., is leaving behind t...

3 biotechs try to trump the summertime warmth by shedding staff

.As biotechs try to switch a new page in August, at the very least 3 companies have dropped workers ...

venBio elevates $528M for fifth lifestyle sciences VC fund

.Pro equity capital firm venBio has lifted yet another half a billion bucks to purchase biotechs foc...

Otsuka pays for $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Pharmaceutical has actually gotten Boston-based Jnana Rehabs for $800 million so the Japanes...

FibroGen lays off 75% of US workers as asset flunks 2 more tests

.FibroGen is significantly restructuring its service, laying off 75% of its united state team as wel...

Tracon wane full weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has actually decided to unwind operations weeks after an injectable invulner...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...

Takeda takes $140M loss on stopped working epilepsy drug, boasts FDA run

.We actually understand that Takeda is actually planning to find a road to the FDA for epilepsy medi...

VBI Vaccines apply for insolvency, finds asset sale

.Immunology biotech VBI Vaccines is drifting alarmingly near to the point of no return, along with s...

Celldex anti-cKIT antitoxin reduce hives in yet another stage 2 research study

.It is actually difficult to muscular tissue in on a space as very competitive as immunology, howeve...